The molecular diagnostics testing lab, which initially filed in late May to go public, said it expects to float its shares on the Nasdaq at between $14 and $16 per share under the ticker symbol PROG.
The molecular diagnostics testing lab, which initially filed in late May to go public, said it expects to float its shares on the Nasdaq at between $14 and $16 per share under the ticker symbol PROG.
Copyright © 2024 | WordPress Theme by MH Themes
